Peptide therapeutics allow for precise delivery of therapeutic agents to cancer cells or damaged tissues. Specific peptides are designed to bind to cancer cells or help repair healthy tissue, ensuring that treatment is focused and effective. This helps reduce damage to healthy cells and tissues, speeds up recovery, and minimizes side effects.
Peptide therapy can help trigger apoptosis of cancer cells, naturally eliminating residual or latent cancer cells, thereby reducing the risk of cancer recurrence. Peptides like p53 mimetic peptides can restore the apoptotic process, ensuring that residual cancer cells are eliminated after primary treatment, promoting a more complete recovery.
In adjuvant therapy, certain peptides can prevent tumor regrowth by inhibiting angiogenesis. These peptides block the vascular endothelial growth factor (VEGF) receptors that cancer cells use to form new blood vessels, effectively starving the tumor and limiting its ability to regenerate.
An important benefit of peptide therapy in cancer recovery is its ability to boost the immune system. Certain peptides can act as immune enhancers, increasing the activity of T cells and natural killer cells (NK cells), which are essential for identifying and destroying cancer cells. This immune modulation not only helps to clear residual cancer cells, but also supports overall recovery by enhancing the body’s natural defenses.
Peptide therapy is often used in combination with traditional treatments such as chemotherapy and radiation therapy to improve patient outcomes. By sensitizing cancer cells to chemotherapy or radiation, peptides can enhance the effectiveness of these treatments while protecting healthy cells. This combination often results in better recovery rates and reduced toxicity, making the post-treatment period more manageable for patients.